This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schinkel, A. H. Articles by Borst, P. Search for Related Content PubMed PubMed Citation Articles by Schinkel, A. H. Articles by Borst, P.

Characterization of the Human MDR3 P-Glycoprotein and Its Recognition by P-Glycoprotein-specific Monoclonal Antibodies¹

Division of Molecular Biology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands

We have cloned a human MDR3 complementary DNA, coding for a P-glycoprotein, into a mammalian expression vector and cotransfected it with a selectable marker into drug-sensitive human BRO melanoma cells. With low frequency we obtained stable, MDR3-expressing clones. Immunocytochemical and immunoblotting analysis of these clones using the monoclonal antibody C219 indicated that human MDR3 P-glycoprotein, like human MDR1 P-glycoprotein, was mainly localized in the plasma membrane and probably glycosylated. Although a significant fraction of the cells (5–10%) in one of the MDR3-expressing clones expressed as much P-glycoprotein as a clearly drug-resistant MDR1-transfected clone, we found no resistance against a range of drugs affected by multidrug resistance. The drugs tested included vincristine, colchicine, VP16-213, daunorubicin, doxorubicin, actinomycin D, and gramicidin D. We did not detect enhanced daunorubicin efflux either in any of the MDR3-expressing cells by fluorescence microscopy. Direct selection with vincristine, actinomycin D, gramicidin D, or daunorubicin of BRO cells transfected with expression constructs containing the regular MDR3 complementary DNA, or a complementary DNA representing a major MDR3 splice variant (C^(-141)), likewise failed to yield resistant clones. Thus, although human MDR3 P-glycoprotein is highly similar to human MDR1 P-glycoprotein, we found no indications that it can transport drugs.

We investigated the cross-reactivity of the monoclonal antibodies C219, C494, JSB-1, HYB-241, and MRK16, recognizing human MDR1 P-glycoprotein, with human MDR3 P-glycoprotein using immunocytochemistry and immunoblotting. Apart from monoclonal antibody C219, none of the monoclonal antibodies showed detectable cross-reactivity with human MDR3 P-glycoprotein. In our hands, monoclonal antibodies MRK16 and HYB-241 were most suitable for sensitive and specific cytochemical detection of human MDR1 P-glycoprotein.

¹ This work was supported by Grant NKI 88-6 of The Netherlands Cancer Society to P. B.

² Present address: Biological Research Unit, Organon-Teknika, Boxtel, The Netherlands.

³ To whom requests for reprints should be addressed.

Received 12/27/90. Accepted 3/ 6/91.

This article has been cited by other articles:

				M. Pajic, J. K. Iyer, A. Kersbergen, E. van der Burg, A. O.H. Nygren, J. Jonkers, P. Borst, and S. Rottenberg Moderate Increase in Mdr1a/1b Expression Causes In vivo Resistance to Doxorubicin in a Mouse Model for Hereditary Breast Cancer Cancer Res., August 15, 2009; 69(16): 6396 - 6404. [Abstract] [Full Text] [PDF]

				G. M. Kalabis, A. Kostaki, M. H. Andrews, S. Petropoulos, W. Gibb, and S. G. Matthews Multidrug Resistance Phosphoglycoprotein (ABCB1) in the Mouse Placenta: Fetal Protection Biol Reprod, October 1, 2005; 73(4): 591 - 597. [Abstract] [Full Text] [PDF]

				Z. Duan, K. A. Brakora, and M. V. Seiden Inhibition of ABCB1 (MDR1) and ABCB4 (MDR3) expression by small interfering RNA and reversal of paclitaxel resistance in human ovarian cancer cells Mol. Cancer Ther., July 1, 2004; 3(7): 833 - 838. [Abstract] [Full Text] [PDF]

				J. Nagayama, M. Iino, Y. Tada, H. Kusaba, A. Kiue, K. Ohshima, M. Kuwano, and M. Wada Retrovirus insertion and transcriptional activation of the multidrug-resistance gene in leukemias treated by a chemotherapeutic agent in vivo Blood, February 1, 2001; 97(3): 759 - 766. [Abstract] [Full Text] [PDF]

				G. L. Scheffer, M. Kool, M. Heijn, Marcel de Haas, A. C. L. M. Pijnenborg, J. Wijnholds, A. van Helvoort, M. C. de Jong, J. H. Hooijberg, C. A. A. M. Mol, et al. Specific Detection of Multidrug Resistance Proteins MRP1, MRP2, MRP3, MRP5, and MDR3 P-Glycoprotein with a Panel of Monoclonal Antibodies Cancer Res., September 1, 2000; 60(18): 5269 - 5277. [Abstract] [Full Text]

				E. Bello-Reuss, S. Ernest, O. B. Holland, and M. R. Hellmich Role of multidrug resistance P-glycoprotein in the secretion of aldosterone by human adrenal NCI-H295 cells Am J Physiol Cell Physiol, June 1, 2000; 278(6): C1256 - C1265. [Abstract] [Full Text] [PDF]

				J. M. H. van den Elsen, D. A. Kuntz, F. J. Hoedemaeker, and D. R. Rose Antibody C219 recognizes an alpha -helical epitope on P-glycoprotein PNAS, November 23, 1999; 96(24): 13679 - 13684. [Abstract] [Full Text] [PDF]

				Y. Zhou, M. M. Gottesman, and I. Pastan Domain Exchangeability between the Multidrug Transporter (MDR1) and Phosphatidylcholine Flippase (MDR2) Mol. Pharmacol., November 1, 1999; 56(5): 997 - 1004. [Abstract] [Full Text]

				H.-J. Kuh, S. H. Jang, M. G. Wientjes, J. R. Weaver, and J. L.-S. Au Determinants of Paclitaxel Penetration and Accumulation in Human Solid Tumor J. Pharmacol. Exp. Ther., August 1, 1999; 290(2): 871 - 880. [Abstract] [Full Text]

				S. Barg, E. Renstrom, P.-O. Berggren, A. Bertorello, K. Bokvist, M. Braun, L. Eliasson, W. E. Holmes, M. Kohler, P. Rorsman, et al. The stimulatory action of tolbutamide on Ca2+-dependent exocytosis in pancreatic beta  cells is mediated by a 65-kDa mdr-like P-glycoprotein PNAS, May 11, 1999; 96(10): 5539 - 5544. [Abstract] [Full Text] [PDF]

				S. Motomura, T. Motoji, M. Takanashi, Y.-H. Wang, H. Shiozaki, I. Sugawara, E. Aikawa, A. Tomida, T. Tsuruo, N. Kanda, et al. Inhibition of P-Glycoprotein and Recovery of Drug Sensitivity of Human Acute Leukemic Blast Cells by Multidrug Resistance Gene (mdr1) Antisense Oligonucleotides Blood, May 1, 1998; 91(9): 3163 - 3171. [Abstract] [Full Text] [PDF]

				M.L. den Boer, R. Pieters, K.M. Kazemier, M.M.A. Rottier, C.M. Zwaan, G.J.L. Kaspers, G. Janka-Schaub, G. Henze, U. Creutzig, R.J. Scheper, et al. Relationship Between Major Vault Protein/Lung Resistance Protein, Multidrug Resistance-Associated Protein, P-Glycoprotein Expression, and Drug Resistance in Childhood Leukemia Blood, March 15, 1998; 91(6): 2092 - 2098. [Abstract] [Full Text] [PDF]

				K. N. Furuya, J. V. Thottassery, E. G. Schuetz, M. Sharif, and J. D. Schuetz Bromocriptine Transcriptionally Activates the Multidrug Resistance Gene (pgp2/mdr1b) by a Novel Pathway J. Biol. Chem., April 25, 1997; 272(17): 11518 - 11525. [Abstract] [Full Text] [PDF]

				J. J. M. Smit, F. Baas, J. E. Hoogendijk, G. H. Jansen, M. A. van der Valk, A. H. Schinkel, A. J. M. Berns, D. Acton, K. Nooter, H. Burger, et al. Peripheral Neuropathy in Mice Transgenic for a Human MDR3 P-Glycoprotein Mini-Gene J. Neurosci., October 15, 1996; 16(20): 6386 - 6393. [Abstract] [Full Text] [PDF]

				S. Ruetz and P. Gros Enhancement of Mdr2-mediated Phosphatidylcholine Translocation by the Bile Salt Taurocholate J. Biol. Chem., October 27, 1995; 270(43): 25388 - 25395. [Abstract] [Full Text] [PDF]

				H Kusaba, K Kohno, K Asakuno, M Kuwano, K Okumura, E D Green, D Schlessinger, and M Wada Functional expression of yeast artificial chromosome-human multidrug resistance genes in mouse cells. Genome Res., October 1, 1995; 5(3): 245 - 258. [Abstract] [PDF]

				X. Zhang, K. I. Collins, and L. M. Greenberger Functional Evidence That Transmembrane 12 and the Loop between Transmembrane 11 and 12 Form Part of the Drug-binding Domain in P-glycoprotein Encoded by MDR1 J. Biol. Chem., March 10, 1995; 270(10): 5441 - 5448. [Abstract] [Full Text] [PDF]

				A. J. Smith, A. van Helvoort, G. van Meer, K. Szabo, E. Welker, G. Szakacs, A. Varadi, B. Sarkadi, and P. Borst MDR3 P-glycoprotein, a Phosphatidylcholine Translocase, Transports Several Cytotoxic Drugs and Directly Interacts with Drugs as Judged by Interference with Nucleotide Trapping J. Biol. Chem., July 28, 2000; 275(31): 23530 - 23539. [Abstract] [Full Text] [PDF]